| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.001 | 0.917 | 5 Hydroxytryptamine release stimulant | 0.906 0.002 DBMET03493 0.569 0.018 DBMET03495 0.853 0.003 DBMET03494 | ||
| 0.639 | 0.004 | 0.639 | Ephrin antagonist | 0.535 0.004 DBMET03493 0.218 0.02 DBMET03495 0.234 0.017 DBMET03494 | ||
| 0.571 | 0.002 | 0.571 | EphA2 antagonist | 0.486 0.002 DBMET03493 0.319 0.004 DBMET03495 0.315 0.004 DBMET03494 | ||
| 0.542 | 0.047 | 0.677 | Caspase 9 stimulant | 0.677 0.027 DBMET03493 0.503 0.058 DBMET03495 0.582 0.039 DBMET03494 | DBMET03493 | |
| 0.487 | 0.03 | 0.491 | Vasodilator, peripheral | 0.491 0.029 DBMET03493 0.201 0.175 DBMET03495 0.438 0.044 DBMET03494 | DBMET03493 | |
| 0.405 | 0.039 | 0.556 | Spasmolytic | 0.46 0.029 DBMET03493 0.466 0.028 DBMET03495 0.556 0.017 DBMET03494 | DBMET03494 | |
| 0.391 | 0.028 | 0.391 | Calcium channel activator | 0.36 0.044 DBMET03493 | ||
| 0.423 | 0.079 | 0.779 | Cyclophilin D inhibitor | 0.454 0.065 DBMET03493 0.726 0.012 DBMET03495 0.779 0.008 DBMET03494 | DBMET03494 | |
| 0.319 | 0.028 | 0.319 | ErbB-1 antagonist | 0.288 0.036 DBMET03493 | ||
| 0.367 | 0.079 | 0.674 | Antiobesity | 0.296 0.119 DBMET03493 0.674 0.013 DBMET03495 0.373 0.077 DBMET03494 | DBMET03495 | |
| 0.281 | 0.004 | 0.281 | Adrenaline uptake inhibitor | 0.204 0.006 DBMET03493 0.072 0.032 DBMET03494 | ||
| 0.295 | 0.028 | 0.295 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.251 0.064 DBMET03493 | ||
| 0.285 | 0.045 | 0.285 | Anticonvulsant | 0.154 0.124 DBMET03493 | ||
| 0.28 | 0.058 | 0.404 | Interleukin agonist | 0.278 0.06 DBMET03493 0.345 0.03 DBMET03495 0.404 0.018 DBMET03494 | DBMET03494 | |
| 0.305 | 0.083 | 0.458 | Vasodilator, coronary | 0.311 0.079 DBMET03493 0.388 0.039 DBMET03495 0.458 0.022 DBMET03494 | DBMET03494 | |
| 0.228 | 0.008 | 0.228 | ErbB-2 antagonist | 0.173 0.013 DBMET03493 | ||
| 0.246 | 0.035 | 0.283 | Nitric-oxide synthase stimulant | 0.283 0.016 DBMET03493 0.279 0.018 DBMET03494 | DBMET03493 | |
| 0.228 | 0.019 | 0.228 | Epidermal growth factor receptor kinase inhibitor | 0.195 0.027 DBMET03493 | ||
| 0.205 | 0.004 | 0.205 | Somatostatin 4 agonist | 0.168 0.004 DBMET03493 0.034 0.03 DBMET03494 | ||
| 0.206 | 0.011 | 0.206 | 5 Hydroxytryptamine uptake inhibitor | 0.103 0.025 DBMET03493 | ||
| 0.206 | 0.014 | 0.206 | Epidermal growth factor antagonist | 0.159 0.021 DBMET03493 | ||
| 0.265 | 0.073 | 0.265 | Cardiotonic | 0.209 0.111 DBMET03493 | ||
| 0.255 | 0.071 | 0.327 | Superoxide dismutase inhibitor | 0.327 0.042 DBMET03493 | DBMET03493 | |
| 0.283 | 0.102 | 0.552 | Cholesterol antagonist | 0.3 0.091 DBMET03493 0.552 0.025 DBMET03495 0.542 0.026 DBMET03494 | DBMET03495 | |
| 0.242 | 0.076 | 0.272 | Tyrosine 3 hydroxylase inhibitor | 0.272 0.049 DBMET03493 | DBMET03493 | |
| 0.243 | 0.078 | 0.44 | Tumour necrosis factor alpha release inhibitor | 0.247 0.076 DBMET03493 0.366 0.034 DBMET03495 0.44 0.021 DBMET03494 | DBMET03494 | |
| 0.258 | 0.101 | 0.258 | Nootropic | |||
| 0.153 | 0.014 | 0.153 | Toll-Like receptor 3 antagonist | 0.101 0.049 DBMET03493 | ||
| 0.148 | 0.011 | 0.148 | EphB4 antagonist | 0.118 0.014 DBMET03493 | ||
| 0.222 | 0.085 | 0.392 | Antiamyloidogenic | 0.315 0.047 DBMET03493 0.268 0.063 DBMET03495 0.392 0.03 DBMET03494 | DBMET03494 | |
| 0.299 | 0.166 | 0.362 | 5 Hydroxytryptamine release inhibitor | 0.314 0.149 DBMET03493 0.362 0.105 DBMET03494 | DBMET03494 | |
| 0.173 | 0.044 | 0.278 | Alpha-N-acetylglucosaminidase inhibitor | 0.173 0.044 DBMET03493 0.228 0.027 DBMET03495 0.278 0.019 DBMET03494 | DBMET03494 | |
| 0.197 | 0.068 | 0.197 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.132 | 0.005 | 0.132 | 5 Hydroxytryptamine 2C agonist | 0.086 0.01 DBMET03493 | ||
| 0.155 | 0.029 | 0.18 | Mucolytic | 0.18 0.019 DBMET03493 0.148 0.034 DBMET03495 0.168 0.023 DBMET03494 | DBMET03493 | |
| 0.288 | 0.168 | 0.358 | Calcium channel L-type activator | 0.358 0.111 DBMET03493 | DBMET03493 | |
| 0.196 | 0.076 | 0.205 | Anesthetic general | 0.184 0.084 DBMET03493 0.205 0.072 DBMET03495 0.155 0.108 DBMET03494 | DBMET03495 | |
| 0.126 | 0.006 | 0.126 | 5 Hydroxytryptamine 2 agonist | 0.078 0.016 DBMET03493 | ||
| 0.126 | 0.009 | 0.126 | Alpha 2 adrenoreceptor agonist | 0.089 0.019 DBMET03493 | ||
| 0.215 | 0.101 | 0.357 | DNA synthesis inhibitor | 0.231 0.082 DBMET03493 0.269 0.056 DBMET03495 0.357 0.029 DBMET03494 | DBMET03494 | |
| 0.151 | 0.04 | 0.151 | Interleukin 1b antagonist | 0.147 0.042 DBMET03493 0.123 0.06 DBMET03494 | ||
| 0.208 | 0.1 | 0.416 | Aldehyde oxidase inhibitor | 0.416 0.045 DBMET03493 | DBMET03493 | |
| 0.144 | 0.037 | 0.236 | DNA repair enzyme inhibitor | 0.137 0.045 DBMET03493 0.173 0.016 DBMET03495 0.236 0.006 DBMET03494 | DBMET03494 | |
| 0.117 | 0.011 | 0.143 | Beta adrenoreceptor antagonist | 0.143 0.006 DBMET03493 | DBMET03493 | |
| 0.205 | 0.101 | 0.346 | Vasodilator | 0.237 0.077 DBMET03493 0.241 0.075 DBMET03495 0.346 0.034 DBMET03494 | DBMET03494 | |
| 0.137 | 0.034 | 0.271 | UDP-glucose 4-epimerase inhibitor | 0.139 0.033 DBMET03493 0.221 0.016 DBMET03495 0.271 0.012 DBMET03494 | DBMET03494 | |
| 0.135 | 0.032 | 0.135 | Alpha 2 adrenoreceptor antagonist | 0.088 0.058 DBMET03493 | ||
| 0.127 | 0.026 | 0.127 | 5 Hydroxytryptamine agonist | |||
| 0.219 | 0.118 | 0.219 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.172 DBMET03493 | ||
| 0.219 | 0.12 | 0.219 | Gastrin inhibitor | |||
| 0.198 | 0.102 | 0.232 | RNA-directed DNA polymerase inhibitor | 0.232 0.063 DBMET03493 0.172 0.149 DBMET03494 | DBMET03493 | |
| 0.248 | 0.156 | 0.309 | GABA C receptor rho-3 antagonist | 0.309 0.11 DBMET03493 | DBMET03493 | |
| 0.139 | 0.049 | 0.139 | Beta amyloid protein antagonist | 0.122 0.065 DBMET03493 0.128 0.059 DBMET03494 | ||
| 0.136 | 0.048 | 0.136 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.129 | 0.045 | 0.391 | Expectorant | 0.161 0.031 DBMET03493 0.271 0.01 DBMET03495 0.391 0.005 DBMET03494 | DBMET03494 | |
| 0.125 | 0.045 | 0.431 | AMP-activated protein kinase stimulant | 0.161 0.022 DBMET03493 0.336 0.004 DBMET03495 0.431 0.004 DBMET03494 | DBMET03494 | |
| 0.143 | 0.064 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.063 DBMET03493 0.135 0.092 DBMET03495 0.135 0.096 DBMET03494 | ||
| 0.124 | 0.047 | 0.124 | Alpha 2c adrenoreceptor antagonist | 0.085 0.082 DBMET03493 | ||
| 0.103 | 0.027 | 0.103 | Alpha adrenoreceptor agonist | 0.072 0.044 DBMET03493 | ||
| 0.101 | 0.028 | 0.101 | Caspase 7 inhibitor | 0.077 0.068 DBMET03493 | ||
| 0.09 | 0.018 | 0.111 | Beta 3 adrenoreceptor antagonist | 0.111 0.012 DBMET03493 | DBMET03493 | |
| 0.144 | 0.074 | 0.155 | Adenylate cyclase stimulant | 0.155 0.054 DBMET03493 | DBMET03493 | |
| 0.251 | 0.182 | 0.251 | Analgesic | |||
| 0.191 | 0.122 | 0.607 | Hypoglycemic | 0.269 0.066 DBMET03493 0.558 0.011 DBMET03495 0.607 0.008 DBMET03494 | DBMET03494 | |
| 0.108 | 0.039 | 0.147 | Phosphodiesterase 6D inhibitor | 0.108 0.038 DBMET03493 0.095 0.063 DBMET03495 0.147 0.01 DBMET03494 | DBMET03494 | |
| 0.108 | 0.044 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.096 0.063 DBMET03493 | ||
| 0.092 | 0.027 | 0.092 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.29 | 0.226 | 0.29 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.085 | 0.027 | 0.085 | Phosphodiesterase VIII inhibitor | 0.069 0.056 DBMET03493 | ||
| 0.168 | 0.111 | 0.221 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.221 0.057 DBMET03493 | DBMET03493 | |
| 0.095 | 0.039 | 0.095 | Alpha 2a adrenoreceptor antagonist | 0.066 0.063 DBMET03493 | ||
| 0.074 | 0.021 | 0.09 | Sphingosine kinase inhibitor | 0.09 0.011 DBMET03493 | DBMET03493 | |
| 0.158 | 0.105 | 0.172 | P-glycoprotein inhibitor | 0.169 0.09 DBMET03493 0.15 0.118 DBMET03495 0.172 0.087 DBMET03494 | DBMET03494 | |
| 0.097 | 0.047 | 0.169 | NADH dehydrogenase inhibitor | 0.103 0.04 DBMET03493 0.169 0.014 DBMET03495 0.159 0.015 DBMET03494 | DBMET03495 | |
| 0.091 | 0.044 | 0.132 | Adrenaline agonist | 0.132 0.02 DBMET03493 | DBMET03493 | |
| 0.11 | 0.066 | 0.11 | Alpha 2b adrenoreceptor antagonist | |||
| 0.107 | 0.067 | 0.107 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.078 | 0.039 | 0.084 | Check point kinase 1 inhibitor | 0.084 0.036 DBMET03493 | DBMET03493 | |
| 0.071 | 0.033 | 0.078 | Prostaglandin EP2 antagonist | 0.063 0.038 DBMET03493 0.078 0.028 DBMET03495 0.075 0.03 DBMET03494 | DBMET03495 | |
| 0.072 | 0.036 | 0.072 | Dopamine D4 antagonist | |||
| 0.095 | 0.059 | 0.095 | Antiadrenergic | |||
| 0.055 | 0.019 | 0.07 | Cytokine production stimulant | 0.07 0.007 DBMET03495 0.055 0.019 DBMET03494 | DBMET03495 | |
| 0.053 | 0.018 | 0.053 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET03493 0.051 0.02 DBMET03495 0.051 0.02 DBMET03494 | ||
| 0.201 | 0.167 | 0.306 | Caspase 3 stimulant | 0.283 0.088 DBMET03493 0.238 0.123 DBMET03495 0.306 0.076 DBMET03494 | DBMET03494 | |
| 0.093 | 0.058 | 0.093 | Adrenaline antagonist | |||
| 0.094 | 0.06 | 0.094 | Alpha adrenoreceptor antagonist | |||
| 0.148 | 0.116 | 0.148 | Succinate dehydrogenase inhibitor | 0.147 0.119 DBMET03493 | ||
| 0.051 | 0.019 | 0.051 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.032 DBMET03493 | ||
| 0.089 | 0.058 | 0.119 | ATPase (Vacuolar H+) inhibitor | 0.087 0.061 DBMET03493 0.101 0.039 DBMET03495 0.119 0.02 DBMET03494 | DBMET03494 | |
| 0.088 | 0.057 | 0.088 | Calcium antagonist | |||
| 0.163 | 0.132 | 0.305 | Cyclic AMP phosphodiesterase inhibitor | 0.177 0.114 DBMET03493 0.305 0.04 DBMET03494 | DBMET03494 | |
| 0.049 | 0.018 | 0.054 | Sphingosine kinase 1 inhibitor | 0.054 0.013 DBMET03493 | DBMET03493 | |
| 0.057 | 0.027 | 0.057 | Dopamine transporter inhibitor | |||
| 0.141 | 0.112 | 0.141 | Tumour necrosis factor antagonist | 0.131 0.125 DBMET03493 | ||
| 0.132 | 0.102 | 0.141 | GABA C receptor rho-2 antagonist | 0.141 0.087 DBMET03493 | DBMET03493 | |
| 0.106 | 0.077 | 0.106 | Anesthetic local | |||
| 0.076 | 0.049 | 0.076 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.076 | 0.049 | 0.08 | Phosphodiesterase VI inhibitor | 0.074 0.053 DBMET03493 0.08 0.04 DBMET03494 | DBMET03494 | |
| 0.082 | 0.056 | 0.082 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.064 | 0.038 | 0.064 | Phosphodiesterase 1C inhibitor | 0.057 0.056 DBMET03493 | ||
| 0.034 | 0.009 | 0.13 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 DBMET03493 0.044 0.006 DBMET03495 0.13 0.002 DBMET03494 | DBMET03494 | |
| 0.071 | 0.046 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.093 0.029 DBMET03493 | DBMET03493 | |
| 0.047 | 0.023 | 0.047 | GABA B receptor antagonist | 0.046 0.025 DBMET03493 | ||
| 0.082 | 0.058 | 0.082 | Acetylcholine M3 receptor agonist | |||
| 0.093 | 0.069 | 0.093 | Sphingomyelinase inhibitor | |||
| 0.097 | 0.075 | 0.164 | Toll-Like receptor 4 antagonist | 0.119 0.045 DBMET03493 0.16 0.016 DBMET03495 0.164 0.014 DBMET03494 | DBMET03494 | |
| 0.111 | 0.089 | 0.141 | Toll-Like receptor 2 antagonist | 0.141 0.059 DBMET03493 | DBMET03493 | |
| 0.109 | 0.089 | 0.443 | Amylase inhibitor | 0.223 0.037 DBMET03493 0.232 0.034 DBMET03495 0.443 0.007 DBMET03494 | DBMET03494 | |
| 0.125 | 0.105 | 0.433 | Hemostatic | 0.134 0.089 DBMET03493 0.19 0.037 DBMET03495 0.433 0.006 DBMET03494 | DBMET03494 | |
| 0.116 | 0.096 | 0.116 | Growth factor antagonist | |||
| 0.077 | 0.057 | 0.088 | Interferon agonist | 0.088 0.041 DBMET03494 | DBMET03494 | |
| 0.103 | 0.084 | 0.103 | Proteasome inhibitor | 0.103 0.083 DBMET03493 | ||
| 0.06 | 0.042 | 0.06 | Phosphodiesterase 1B inhibitor | |||
| 0.046 | 0.028 | 0.046 | Sphingosine 1-phosphate receptor agonist | |||
| 0.074 | 0.056 | 0.077 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.077 0.052 DBMET03493 | DBMET03493 | |
| 0.114 | 0.097 | 0.123 | Interleukin 1 antagonist | 0.123 0.085 DBMET03493 | DBMET03493 | |
| 0.032 | 0.016 | 0.032 | Uridine phosphorylase inhibitor | 0.031 0.017 DBMET03494 | ||
| 0.023 | 0.007 | 0.023 | Alpha 2b adrenoreceptor agonist | |||
| 0.161 | 0.145 | 0.477 | Immunostimulant | 0.218 0.11 DBMET03493 0.425 0.043 DBMET03495 0.477 0.032 DBMET03494 | DBMET03494 | |
| 0.055 | 0.04 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 DBMET03493 | DBMET03493 | |
| 0.149 | 0.134 | 0.164 | Insulin sensitizer | 0.164 0.114 DBMET03493 0.154 0.128 DBMET03494 | DBMET03493 | |
| 0.062 | 0.048 | 0.068 | Interferon inducer | 0.068 0.038 DBMET03494 | DBMET03494 | |
| 0.054 | 0.04 | 0.068 | Sphingosine kinase 2 inhibitor | 0.068 0.024 DBMET03493 | DBMET03493 | |
| 0.04 | 0.026 | 0.04 | MAP3K5 inhibitor | |||
| 0.112 | 0.098 | 0.112 | Toll-Like receptor antagonist | |||
| 0.046 | 0.033 | 0.046 | CC chemokine 4 receptor antagonist | |||
| 0.024 | 0.012 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 DBMET03493 | ||
| 0.047 | 0.035 | 0.061 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 DBMET03493 0.06 0.018 DBMET03495 0.061 0.018 DBMET03494 | DBMET03494 | |
| 0.042 | 0.031 | 0.042 | GHS receptor agonist | |||
| 0.055 | 0.044 | 0.057 | Leukotriene C antagonist | 0.057 0.038 DBMET03493 | DBMET03493 | |
| 0.044 | 0.033 | 0.102 | Mannosidase inhibitor | 0.044 0.034 DBMET03493 0.072 0.011 DBMET03495 0.102 0.005 DBMET03494 | DBMET03494 | |
| 0.034 | 0.024 | 0.034 | Growth hormone secretagogue receptor agonist | |||
| 0.034 | 0.025 | 0.034 | Glutamate (mGluR group II) agonist | |||
| 0.095 | 0.086 | 0.111 | GABA C receptor antagonist | 0.111 0.062 DBMET03493 | DBMET03493 | |
| 0.053 | 0.044 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.031 | 0.023 | 0.031 | Glutamate (mGluR2) agonist | |||
| 0.081 | 0.075 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.059 | 0.053 | 0.069 | Beta 2 adrenoreceptor agonist | 0.069 0.022 DBMET03493 | DBMET03493 | |
| 0.047 | 0.041 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.025 | 0.02 | 0.106 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET03493 0.054 0.005 DBMET03495 0.106 0.003 DBMET03494 | DBMET03494 | |
| 0.033 | 0.028 | 0.033 | Renin inhibitor | |||
| 0.029 | 0.024 | 0.029 | Somatostatin agonist | |||
| 0.018 | 0.013 | 0.018 | Alpha 2c adrenoreceptor agonist | |||
| 0.056 | 0.052 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.072 | 0.068 | 0.072 | Phosphodiesterase 3A inhibitor | |||
| 0.087 | 0.084 | 0.094 | GABA C receptor rho-1 antagonist | 0.094 0.072 DBMET03493 | DBMET03493 | |
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.032 | 0.029 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.026 DBMET03493 | ||
| 0.08 | 0.077 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.034 | 0.032 | 0.034 | Diamine oxidase inhibitor | |||
| 0.066 | 0.064 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.079 0.052 DBMET03493 0.086 0.044 DBMET03495 0.104 0.028 DBMET03494 | DBMET03494 | |
| 0.079 | 0.08 | 0.091 | Aminoacyl-tRNA synthetase inhibitor | 0.091 0.057 DBMET03493 | DBMET03493 | |
| 0.077 | 0.083 | 0.127 | Triose-phosphate isomerase inhibitor | 0.127 0.029 DBMET03495 0.117 0.034 DBMET03494 | DBMET03495 | |
| 0.114 | 0.121 | 0.306 | Insulin secretagoues | 0.124 0.105 DBMET03493 0.306 0.012 DBMET03495 0.261 0.018 DBMET03494 | DBMET03495 | |
| 0.046 | 0.053 | 0.085 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET03495 0.085 0.009 DBMET03494 | DBMET03494 | |
| 0.077 | 0.084 | 0.109 | MAO A inhibitor | 0.109 0.059 DBMET03493 | DBMET03493 | |
| 0.016 | 0.025 | 0.029 | Antibiotic Anthracycline-like | 0.029 0.004 DBMET03495 0.024 0.006 DBMET03494 | DBMET03495 | |
| 0.051 | 0.064 | 0.065 | Dopamine D1 antagonist | 0.065 0.044 DBMET03493 | DBMET03493 | |
| 0.153 | 0.167 | 0.186 | DNA damaging | 0.168 0.147 DBMET03493 0.186 0.128 DBMET03495 0.173 0.142 DBMET03494 | DBMET03495 | |
| 0.107 | 0.123 | 0.145 | Vanilloid 1 agonist | 0.116 0.099 DBMET03493 0.145 0.044 DBMET03495 | DBMET03495 | |
| 0.03 | 0.048 | 0.04 | Dopamine D5 agonist | 0.04 0.027 DBMET03493 | DBMET03493 | |
| 0.022 | 0.04 | 0.033 | Toll-Like receptor 4 agonist | 0.031 0.01 DBMET03495 0.033 0.009 DBMET03494 | DBMET03494 | |
| 0.037 | 0.057 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 DBMET03493 | DBMET03493 | |
| 0.131 | 0.152 | 0.144 | Phospholipase C inhibitor | 0.144 0.118 DBMET03493 | DBMET03493 | |
| 0.1 | 0.121 | 0.249 | Protein kinase stimulant | 0.148 0.07 DBMET03493 0.159 0.062 DBMET03495 0.249 0.027 DBMET03494 | DBMET03494 | |
| 0.19 | 0.214 | 0.388 | Histamine release inhibitor | 0.242 0.161 DBMET03493 0.242 0.162 DBMET03495 0.388 0.082 DBMET03494 | DBMET03494 | |
| 0.132 | 0.158 | 0.343 | Hypolipemic | 0.153 0.134 DBMET03493 0.343 0.037 DBMET03495 0.281 0.055 DBMET03494 | DBMET03495 | |
| 0.09 | 0.12 | 0.248 | Cyclooxygenase 3 inhibitor | 0.102 0.1 DBMET03493 0.165 0.037 DBMET03495 0.248 0.009 DBMET03494 | DBMET03494 | |
| 0.082 | 0.114 | 0.215 | Alkylator | 0.102 0.086 DBMET03493 0.215 0.022 DBMET03495 0.191 0.029 DBMET03494 | DBMET03495 | |
| 0.077 | 0.111 | 0.118 | Interleukin 12 antagonist | 0.101 0.052 DBMET03493 0.118 0.031 DBMET03494 | DBMET03494 | |
| 0.038 | 0.073 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET03493 | DBMET03493 | |
| 0.085 | 0.12 | 0.175 | Microtubule formation inhibitor | 0.175 0.027 DBMET03495 0.101 0.089 DBMET03494 | DBMET03495 | |
| 0.079 | 0.116 | 0.102 | MAO inhibitor | 0.102 0.088 DBMET03493 | DBMET03493 | |
| 0.07 | 0.109 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.064 DBMET03493 | DBMET03493 | |
| 0.057 | 0.097 | 0.108 | Macrophage migration inhibitory factor inhibitor | 0.108 0.031 DBMET03493 | DBMET03493 | |
| 0.025 | 0.065 | 0.068 | Antibiotic Aminoglycoside-like | 0.061 0.008 DBMET03495 0.068 0.006 DBMET03494 | DBMET03494 | |
| 0.071 | 0.115 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.08 DBMET03493 | DBMET03493 | |
| 0.067 | 0.111 | 0.188 | Mediator release inhibitor | 0.091 0.08 DBMET03493 0.137 0.035 DBMET03495 0.188 0.017 DBMET03494 | DBMET03494 | |
| 0.129 | 0.173 | 0.18 | Neurotrophic factor enhancer | 0.178 0.1 DBMET03493 0.18 0.098 DBMET03494 | DBMET03494 | |
| 0.112 | 0.157 | 0.239 | DNA methyltransferase I inhibitor | 0.146 0.109 DBMET03493 0.239 0.052 DBMET03494 | DBMET03494 | |
| 0.072 | 0.12 | 0.094 | Bile acid receptor antagonist | 0.094 0.063 DBMET03493 | DBMET03493 | |
| 0.111 | 0.16 | 0.214 | Interferon gamma antagonist | 0.132 0.106 DBMET03493 0.139 0.094 DBMET03495 0.214 0.036 DBMET03494 | DBMET03494 | |
| 0.073 | 0.125 | 0.095 | Carbonic anhydrase XV inhibitor | 0.095 0.075 DBMET03493 | DBMET03493 | |
| 0.063 | 0.117 | 0.078 | MAP kinase kinase 7 inhibitor | 0.078 0.053 DBMET03493 | DBMET03493 | |
| 0.074 | 0.129 | 0.097 | Cholesterol synthesis inhibitor | 0.097 0.092 DBMET03493 | DBMET03493 | |
| 0.038 | 0.093 | 0.09 | Phosphofructokinase-1 inhibitor | 0.078 0.042 DBMET03495 0.09 0.036 DBMET03494 | DBMET03494 | |
| 0.112 | 0.168 | 0.395 | Hepatoprotectant | 0.171 0.088 DBMET03493 0.349 0.019 DBMET03495 0.395 0.014 DBMET03494 | DBMET03494 | |
| 0.168 | 0.223 | 0.58 | Antithrombotic | 0.478 0.032 DBMET03495 0.58 0.018 DBMET03494 | DBMET03494 | |
| 0.02 | 0.078 | 0.039 | Purinergic P2Y antagonist | 0.039 0.038 DBMET03495 | DBMET03495 | |
| 0.042 | 0.103 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET03495 0.066 0.02 DBMET03494 | DBMET03495 | |
| 0.072 | 0.136 | 0.239 | Beta glucuronidase inhibitor | 0.104 0.063 DBMET03493 0.11 0.056 DBMET03495 0.239 0.009 DBMET03494 | DBMET03494 | |
| 0.04 | 0.107 | 0.077 | Histidine decarboxylase inhibitor | 0.077 0.044 DBMET03493 | DBMET03493 | |
| 0.166 | 0.238 | 0.405 | Apoptosis antagonist | 0.243 0.135 DBMET03493 0.391 0.041 DBMET03495 0.405 0.037 DBMET03494 | DBMET03494 | |
| 0.149 | 0.221 | 0.228 | Hypoxia-inducible factor 1 alpha inhibitor | 0.214 0.136 DBMET03493 0.207 0.143 DBMET03495 0.228 0.121 DBMET03494 | DBMET03494 | |
| 0.064 | 0.137 | 0.098 | Carbonic anhydrase III inhibitor | 0.098 0.065 DBMET03493 | DBMET03493 | |
| 0.106 | 0.181 | 0.235 | DNA methylase inhibitor | 0.235 0.057 DBMET03494 | DBMET03494 | |
| 0.18 | 0.255 | 0.61 | Antibacterial | 0.266 0.162 DBMET03493 0.52 0.035 DBMET03495 0.61 0.018 DBMET03494 | DBMET03494 | |
| 0.058 | 0.136 | 0.115 | Creatine kinase inhibitor | 0.115 0.045 DBMET03493 | DBMET03493 | |
| 0.149 | 0.228 | 0.541 | Transcription factor NF kappa B inhibitor | 0.254 0.125 DBMET03493 0.462 0.05 DBMET03495 0.541 0.039 DBMET03494 | DBMET03494 | |
| 0.041 | 0.121 | 0.071 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.071 0.06 DBMET03493 | DBMET03493 | |
| 0.028 | 0.112 | 0.329 | Selectin antagonist | 0.305 0.005 DBMET03495 0.329 0.004 DBMET03494 | DBMET03494 | |
| 0.008 | 0.092 | 0.049 | Arginase inhibitor | 0.049 0.016 DBMET03494 | DBMET03494 | |
| 0.049 | 0.134 | 0.074 | Glycine receptor antagonist | 0.074 0.066 DBMET03494 | DBMET03494 | |
| 0.027 | 0.114 | 0.051 | Cholesterol esterase inhibitor | 0.051 0.028 DBMET03495 | DBMET03495 | |
| 0.16 | 0.254 | 0.548 | Alpha-glucosidase inhibitor | 0.277 0.172 DBMET03493 0.548 0.067 DBMET03495 0.529 0.072 DBMET03494 | DBMET03495 | |
| 0.011 | 0.105 | 0.041 | Protein 30S ribosomal subunit inhibitor | 0.034 0.011 DBMET03495 0.041 0.01 DBMET03494 | DBMET03494 | |
| 0.023 | 0.119 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 DBMET03495 0.088 0.017 DBMET03494 | DBMET03494 | |
| 0.077 | 0.181 | 0.15 | Peroxidase inhibitor | 0.15 0.078 DBMET03493 | DBMET03493 | |
| 0.091 | 0.202 | 0.341 | Nitric oxide antagonist | 0.15 0.095 DBMET03493 0.313 0.038 DBMET03495 0.341 0.033 DBMET03494 | DBMET03494 | |
| 0.077 | 0.191 | 0.611 | Angiogenesis stimulant | 0.177 0.106 DBMET03493 0.524 0.01 DBMET03495 0.611 0.006 DBMET03494 | DBMET03494 | |
| 0.068 | 0.184 | 0.113 | Photosensitizer | 0.113 0.067 DBMET03494 | DBMET03494 | |
| 0.017 | 0.134 | 0.034 | Estrogen-related receptor beta antagonist | 0.034 0.019 DBMET03493 | DBMET03493 | |
| 0.039 | 0.164 | 0.236 | Monophenol monooxygenase inhibitor | 0.106 0.071 DBMET03493 0.094 0.08 DBMET03495 0.236 0.026 DBMET03494 | DBMET03494 | |
| 0.064 | 0.191 | 0.283 | Thrombolytic | 0.219 0.044 DBMET03495 0.283 0.027 DBMET03494 | DBMET03494 | |
| 0.028 | 0.157 | 0.083 | Heparanase inhibitor | 0.055 0.033 DBMET03495 0.083 0.006 DBMET03494 | DBMET03494 | |
| 0.02 | 0.15 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.042 0.038 DBMET03495 0.046 0.031 DBMET03494 | DBMET03494 | |
| 0.01 | 0.155 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET03494 | DBMET03494 | |
| 0.027 | 0.173 | 0.076 | Neuraminidase (influenza) inhibitor | 0.071 0.033 DBMET03495 0.076 0.028 DBMET03494 | DBMET03494 | |
| 0.052 | 0.198 | 0.139 | Xanthine oxidase inhibitor | 0.139 0.039 DBMET03494 | DBMET03494 | |
| 0.101 | 0.25 | 0.537 | Antioxidant | 0.26 0.079 DBMET03493 0.454 0.026 DBMET03495 0.537 0.016 DBMET03494 | DBMET03494 | |
| 0.026 | 0.176 | 0.078 | Factor IXa inhibitor | 0.068 0.022 DBMET03495 0.078 0.017 DBMET03494 | DBMET03494 | |
| 0.007 | 0.16 | 0.02 | Purinergic P2Y12 antagonist | 0.02 0.019 DBMET03495 | DBMET03495 | |
| 0.055 | 0.212 | 0.258 | Lipid peroxidase inhibitor | 0.153 0.066 DBMET03493 0.192 0.045 DBMET03495 0.258 0.025 DBMET03494 | DBMET03494 | |
| 0.084 | 0.244 | 0.168 | Melanin inhibitor | 0.126 0.122 DBMET03493 0.168 0.061 DBMET03494 | DBMET03494 | |
| 0.074 | 0.234 | 0.139 | Farnesoid X receptor antagonist | 0.139 0.067 DBMET03493 | DBMET03493 | |
| 0.052 | 0.212 | 0.118 | Transcription factor NF kappa B stimulant | 0.114 0.028 DBMET03495 0.118 0.026 DBMET03494 | DBMET03494 | |
| 0.124 | 0.285 | 0.349 | Peptidyltransferase inhibitor | 0.163 0.162 DBMET03493 0.321 0.018 DBMET03495 0.349 0.012 DBMET03494 | DBMET03494 | |
| 0.023 | 0.185 | 0.06 | Nitric oxide donor | 0.06 0.049 DBMET03494 | DBMET03494 | |
| 0.096 | 0.26 | 0.182 | ATPase inhibitor | 0.182 0.055 DBMET03494 | DBMET03494 | |
| 0.086 | 0.254 | 0.28 | Platelet antagonist | 0.28 0.06 DBMET03495 0.272 0.063 DBMET03494 | DBMET03495 | |
| 0.125 | 0.294 | 0.434 | Immunosuppressant | 0.385 0.07 DBMET03495 0.434 0.052 DBMET03494 | DBMET03494 | |
| 0.077 | 0.249 | 0.35 | Platelet adhesion inhibitor | 0.32 0.028 DBMET03495 0.35 0.019 DBMET03494 | DBMET03494 | |
| 0.077 | 0.249 | 0.142 | Interleukin antagonist | 0.142 0.124 DBMET03493 | DBMET03493 | |
| 0.068 | 0.247 | 0.228 | Cell wall synthesis inhibitor | 0.162 0.055 DBMET03495 0.228 0.021 DBMET03494 | DBMET03494 | |
| 0.017 | 0.198 | 0.142 | Antineoplastic antibiotic | 0.125 0.037 DBMET03495 0.142 0.033 DBMET03494 | DBMET03494 | |
| 0.027 | 0.21 | 0.119 | Topoisomerase II alpha inhibitor | 0.082 0.051 DBMET03495 0.119 0.03 DBMET03494 | DBMET03494 | |
| 0.061 | 0.248 | 0.211 | Anticoagulant | 0.177 0.063 DBMET03495 0.211 0.049 DBMET03494 | DBMET03494 | |
| 0.103 | 0.295 | 0.178 | 12-Lipoxygenase inhibitor | 0.178 0.175 DBMET03493 | DBMET03493 | |
| 0.017 | 0.21 | 0.045 | Microtubule stabilization | 0.045 0.035 DBMET03495 | DBMET03495 | |
| 0.098 | 0.293 | 0.173 | Lipoxygenase inhibitor | 0.173 0.172 DBMET03493 | DBMET03493 | |
| 0.03 | 0.23 | 0.181 | Topoisomerase I inhibitor | 0.174 0.033 DBMET03495 0.181 0.031 DBMET03494 | DBMET03494 | |
| 0.014 | 0.219 | 0.063 | Neuraminidase inhibitor | 0.054 0.052 DBMET03495 0.063 0.04 DBMET03494 | DBMET03494 | |
| 0.073 | 0.285 | 0.177 | Interleukin 6 antagonist | 0.177 0.057 DBMET03494 | DBMET03494 | |
| 0.044 | 0.256 | 0.11 | DNA polymerase I inhibitor | 0.107 0.079 DBMET03495 0.11 0.076 DBMET03494 | DBMET03494 | |
| 0.049 | 0.264 | 0.084 | Vanilloid agonist | 0.084 0.059 DBMET03495 | DBMET03495 | |
| 0.072 | 0.299 | 0.484 | Free radical scavenger | 0.235 0.075 DBMET03493 0.409 0.027 DBMET03495 0.484 0.018 DBMET03494 | DBMET03494 | |
| 0.142 | 0.376 | 0.501 | Apoptosis agonist | 0.275 0.191 DBMET03493 0.431 0.099 DBMET03495 0.501 0.074 DBMET03494 | DBMET03494 | |
| 0.099 | 0.335 | 0.27 | Angiogenesis inhibitor | 0.27 0.109 DBMET03494 | DBMET03494 | |
| 0.048 | 0.296 | 0.129 | Estrogen antagonist | 0.129 0.039 DBMET03493 | DBMET03493 | |
| 0.069 | 0.318 | 0.181 | Non-steroidal antiinflammatory agent | 0.181 0.086 DBMET03494 | DBMET03494 | |
| 0.03 | 0.289 | 0.182 | Topoisomerase II inhibitor | 0.127 0.062 DBMET03495 0.182 0.038 DBMET03494 | DBMET03494 | |
| 0.107 | 0.368 | 0.199 | Sodium/bile acid cotransporter inhibitor | 0.199 0.189 DBMET03493 | DBMET03493 | |
| 0.15 | 0.417 | 0.697 | Antiinflammatory | 0.259 0.257 DBMET03493 0.513 0.082 DBMET03495 0.697 0.031 DBMET03494 | DBMET03494 | |
| 0.037 | 0.305 | 0.099 | Thioredoxin inhibitor | 0.099 0.049 DBMET03494 | DBMET03494 | |
| 0.057 | 0.327 | 0.167 | Hexokinase inhibitor | 0.167 0.061 DBMET03494 | DBMET03494 | |
| 0.12 | 0.395 | 0.402 | Interleukin 2 agonist | 0.402 0.027 DBMET03495 0.369 0.038 DBMET03494 | DBMET03495 | |
| 0.032 | 0.346 | 0.057 | Lipocortins synthesis agonist | 0.055 0.048 DBMET03495 0.057 0.043 DBMET03494 | DBMET03494 | |
| 0.021 | 0.367 | 0.073 | Histone deacetylase SIRT1 stimulant | 0.073 0.051 DBMET03494 | DBMET03494 | |
| 0.021 | 0.367 | 0.073 | Histone deacetylase stimulant | 0.073 0.051 DBMET03494 | DBMET03494 | |
| 0.044 | 0.398 | 0.112 | Interleukin 4 antagonist | 0.108 0.104 DBMET03493 0.112 0.097 DBMET03494 | DBMET03494 | |
| 0.026 | 0.384 | 0.093 | Uric acid excretion stimulant | 0.085 0.073 DBMET03495 0.093 0.061 DBMET03494 | DBMET03494 | |
| 0.016 | 0.395 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.057 0.028 DBMET03495 0.068 0.017 DBMET03494 | DBMET03494 | |
| 0.049 | 0.447 | 0.23 | NOS3 expression enhancer | 0.151 0.071 DBMET03495 0.23 0.031 DBMET03494 | DBMET03494 | |
| 0.02 | 0.467 | 0.108 | Estrogen receptor beta antagonist | 0.108 0.05 DBMET03493 | DBMET03493 | |
| 0.009 | 0.504 | 0.083 | Lipase inhibitor | 0.083 0.04 DBMET03495 | DBMET03495 | |
| 0.05 | 0.575 | 0.313 | Immunomodulator | 0.285 0.091 DBMET03495 0.313 0.075 DBMET03494 | DBMET03494 | |
| 0.021 | 0.597 | 0.19 | Amyloid beta precursor protein antagonist | 0.19 0.064 DBMET03495 | DBMET03495 | |
| 0.007 | 0.714 | 0.108 | Cell adhesion molecule inhibitor | 0.108 0.029 DBMET03495 | DBMET03495 | |
| 0.012 | 0.749 | 0.222 | Cell adhesion inhibitor | 0.222 0.019 DBMET03495 0.137 0.054 DBMET03494 | DBMET03495 | |
| 0.054 | 0.866 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.092 DBMET03494 | DBMET03494 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |